Nova Leap Health (CVE:NLH) Sets New 52-Week High – Should You Buy?

Nova Leap Health Corp. (CVE:NLH)’s stock price hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as C$0.44 and last traded at C$0.44, with a volume of 50600 shares changing hands. The stock had previously closed at C$0.41.

Nova Leap Health Price Performance

The business has a fifty day moving average of C$0.38 and a 200 day moving average of C$0.34. The firm has a market cap of C$37.98 million, a P/E ratio of 145.00 and a beta of 1.96. The company has a quick ratio of 1.13, a current ratio of 1.02 and a debt-to-equity ratio of 14.80.

Insider Buying and Selling at Nova Leap Health

In other news, Director R. Wayne Myles acquired 61,000 shares of the firm’s stock in a transaction on Friday, May 15th. The shares were purchased at an average cost of C$0.44 per share, with a total value of C$26,840.00. Following the acquisition, the director directly owned 2,446,761 shares in the company, valued at C$1,076,574.84. This represents a 2.56% increase in their position. Insiders purchased a total of 168,471 shares of company stock worth $69,930 in the last 90 days. 40.77% of the stock is currently owned by company insiders.

About Nova Leap Health

Nova Leap Health Corp., together with its subsidiaries, provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and skilled nursing care, respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders. The company was incorporated in 2015 and is headquartered in Halifax, Canada.